发明授权
- 专利标题： Bradykinin antagonist quinolines
- 专利标题（中）： 缓激肽拮抗剂喹啉
-
申请号： US233771申请日： 1994-04-26
-
公开(公告)号： US5563162A公开(公告)日： 1996-10-08
- 发明人: Teruo Oku , Hiroshi Kayakiri , Shigeki Satoh , Yoshito Abe , Yuki Sawada , Takayuki Inoue , Hirokazu Tanaka
- 申请人： Teruo Oku , Hiroshi Kayakiri , Shigeki Satoh , Yoshito Abe , Yuki Sawada , Takayuki Inoue , Hirokazu Tanaka
- 申请人地址： JPX Osaka
- 专利权人： Fujisawa Pharmaceutical Co., Ltd.
- 当前专利权人： Fujisawa Pharmaceutical Co., Ltd.
- 当前专利权人地址： JPX Osaka
- 优先权： GBX9308804 19930428; GBX9318929 19930913
- 主分类号： A61K31/47
- IPC分类号： A61K31/47 ; A61K31/495 ; A61K31/498 ; A61K31/50 ; A61K31/502 ; A61K31/505 ; A61K31/517 ; A61K31/53 ; A61P35/00 ; A61P37/08 ; A61P43/00 ; C07D215/24 ; C07D215/26 ; C07D215/40 ; C07D237/10 ; C07D237/28 ; C07D239/74 ; C07D241/42 ; C07D241/44 ; C07D401/12 ; C07D401/14 ; C07D403/12 ; C07D409/12 ; C07D413/12 ; C07F7/18 ; C07D215/02
摘要：
This invention relates to new heterocyclic compounds and pharmaceutically acceptable salts thereof. More particularly, this invention relates to new heterocyclic compounds and salts thereof which display bradykinin antagonist activity, to processes for preparing these compounds, to a pharmaceutical composition comprising these compounds, and to methods of using same in the prevention and/or the treatment of bradykinin- or bradykinin analogue-mediated diseases such as allergy, inflammation, autoimmune disease, shock, pain, or the like, in human beings or in animals.
公开/授权文献
信息查询
